Navigate Up

UPMC/University of Pittsburgh Schools of the Health Sciences
For Journalists
Allison Hydzik
Manager
Telephone: 412-647-9975
Manager
Telephone: 412-647-9966
Other Inquiries

Viral Infections, Including Flu, Could Be Inhibited by Naturally Occurring Protein, UPCI Finds

PITTSBURGH, June 12, 2014 – By boosting a protein that naturally exists in our cells, an international team of researchers led by the University of Pittsburgh Cancer Institute (UPCI), partner with UPMC CancerCenter, has found a potential way to enhance our ability to sense and inhibit viral infections.
 
The laboratory-based discovery, which could lead to more effective treatments for viruses ranging from hepatitis C to the flu, appears in the June 19 issue of the journal Immunity. The research is supported by the National Institutes of Health.
 
“Despite remarkable advances in vaccination and treatment, diseases caused by viral infections remain among the leading causes of death worldwide,” said senior author Saumendra N. Sarkar, Ph.D., assistant professor of microbiology and molecular genetics at UPCI. “We need new defenses against viral infections, and our discovery is proving to be a promising avenue for further exploration.”
 
Dr. Sarkar and his team made the discovery while investigating a protein called oligoadenylate synthetases-like, or OASL, which appears in increased quantities in people with liver cancer caused by the hepatitis C virus.
 
Hepatitis C, influenza, the childhood respiratory illness RSV, and many other viruses are known as ribonucleic acid (RNA) viruses, which use RNA as their genetic material when they replicate. The OASL protein enhances cells’ ability to detect virus RNA, activating the immune system to sense the virus and inhibit replication.
 
In laboratory tests, boosting this protein in human cells effectively inhibits viral replication. Conversely, mice that do not have OASL were found to be much more susceptible to viral infections.
 
The finding is especially notable because it may offer an alternative to interferons, another kind of protein that is made and released by cells in response to viruses. Interferons are used in therapy against some viral infections, including hepatitis C, but are not effective for other RNA viruses, such as influenza. Interferon therapy also has major side effects, and not all patients respond well to treatment.
 
Dr. Sarkar and his team plan to determine the most efficient way to boost the OASL pathway in patients and are working with pulmonologists to develop and identify funding for a study to evaluate the effect of boosting OASL in people with lung infections.
 
“The respiratory system is a much easier target to deliver this type of therapy, compared to an organ, such as the liver, so we’ll be starting with infections like RSV,” said Dr. Sarkar. “From there we could branch out to other RNA viruses and perhaps find effective ways to boost our inherent immunity against a broad range of viral infections.”
 
Additional authors on this study are Jianzhong Zhu, Ph.D., Yugen Zhang, Ph.D., Arundhati Ghosh, Ph.D., Rolanodo A. Cuevas, M.S., Adriana Forero, Ph.D., Madhavi K. Ganapathiraju, Ph.D., Carolyn B. Coyne, Ph.D., all of Pitt; Jayeeta Dhar, Ph.D., and Sailen Barik, Ph.D., both of Cleveland State University; Mikkel Søes Ibsen, M.S., and Rune Hartmann, Ph.D., both of Aarhus University in Denmark; Jonathan Leo Schmid-Burgk, M.S., Tobias Schmidt, M.S., and Veit Hornung, Ph.D., all of the University of Bonn in Germany; and Takashi Fujita, Ph.D., of Kyoto University in Japan.
 
This research was supported by National Institute of Allergy and Infectious Diseases grant no. AI082673 and UPCI.

©  UPMC | Affiliated with the University of Pittsburgh Schools of the Health Sciences
Supplemental content provided by A.D.A.M. Health Solutions. All rights reserved.

For help in finding a doctor or health service that suits your needs, call the UPMC Referral Service at 412-647-UPMC (8762) or 1-800-533-UPMC (8762). Select option 1.

UPMC is an equal opportunity employer. UPMC policy prohibits discrimination or harassment on the basis of race, color, religion, ancestry, national origin, age, sex, genetics, sexual orientation, marital status, familial status, disability, veteran status, or any other legally protected group status. Further, UPMC will continue to support and promote equal employment opportunity, human dignity, and racial, ethnic, and cultural diversity. This policy applies to admissions, employment, and access to and treatment in UPMC programs and activities. This commitment is made by UPMC in accordance with federal, state, and/or local laws and regulations.

Medical information made available on UPMC.com is not intended to be used as a substitute for professional medical advice, diagnosis, or treatment. You should not rely entirely on this information for your health care needs. Ask your own doctor or health care provider any specific medical questions that you have. Further, UPMC.com is not a tool to be used in the case of an emergency. If an emergency arises, you should seek appropriate emergency medical services.

For UPMC Mercy Patients: As a Catholic hospital, UPMC Mercy abides by the Ethical and Religious Directives for Catholic Health Care Services, as determined by the United States Conference of Catholic Bishops. As such, UPMC Mercy neither endorses nor provides medical practices and/or procedures that contradict the moral teachings of the Roman Catholic Church.

© UPMC
Pittsburgh, PA, USA UPMC.com